We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTHM icon
4176
Fathom Holdings
FTHM
$25.7M
$13K ﹤0.01%
626
-349
-36% -$8.13K
GORO icon
4177
Goldgroup Mining
GORO
$207M
$13K ﹤0.01%
8,240
-4
-0% -$7
GTE icon
4178
Gran Tierra Energy
GTE
$325M
$13K ﹤0.01%
+1,690
New +$13.8K
HBT icon
4179
HBT Financial
HBT
$1.35B
$13K ﹤0.01%
677
-1,046
-61% -$18.9K
HFBL icon
4180
Home Federal Bancorp
HFBL
$73M
$13K ﹤0.01%
641
-145
-18% -$2.83K
HIFS icon
4181
Hingham Institution for Saving
HIFS
$680M
$13K ﹤0.01%
30
-64
-68% -$24.1K
HTLD icon
4182
Heartland Express
HTLD
$989M
$13K ﹤0.01%
801
-493
-38% -$8.27K
IIIV icon
4183
i3 Verticals
IIIV
$294M
$13K ﹤0.01%
554
-768
-58% -$17.2K
INVE icon
4184
Identive
INVE
$64.2M
$13K ﹤0.01%
467
-187
-29% -$4.11K
KRMD icon
4185
KORU Medical Systems
KRMD
$157M
$13K ﹤0.01%
4,087
+429
+12% +$1.31K
LGL icon
4186
LGL Group
LGL
$93.6M
$13K ﹤0.01%
3,023
+2,347
+347% +$10.7K
LTRN icon
4187
Lantern Pharma
LTRN
$33.9M
$13K ﹤0.01%
1,612
+1,082
+204% +$9.88K
MEOH icon
4188
Methanex
MEOH
$4.34B
$13K ﹤0.01%
334
-1,507
-82% -$66.9K
MESO
4189
Mesoblast
MESO
$2.02B
$13K ﹤0.01%
+1,402
New +$16.3K
MYPS icon
4190
PLAYSTUDIOS Inc
MYPS
$63.1M
$13K ﹤0.01%
+3,280
New +$14.2K
NFBK
4191
DELISTED
Northfield Bancorp
NFBK
$13K ﹤0.01%
789
-670
-46% -$11.6K
NRDY icon
4192
Nerdy
NRDY
$90.4M
$13K ﹤0.01%
+2,825
New +$20.2K
OI icon
4193
O-I Glass
OI
$1.04B
$13K ﹤0.01%
1,100
-9,177
-89% -$116K
PAHC icon
4194
Phibro Animal Health
PAHC
$1.39B
$13K ﹤0.01%
652
-666
-51% -$14.2K
PRVA icon
4195
Privia Health
PRVA
$2.81B
$13K ﹤0.01%
491
-1,003
-67% -$25K
PWOD
4196
DELISTED
Penns Woods Bancorp
PWOD
$13K ﹤0.01%
544
+383
+238% +$9.17K
QSI icon
4197
Quantum-Si Incorporated
QSI
$162M
$13K ﹤0.01%
1,658
+1,630
+5,821% +$12.3K
RENT
4198
Rent the Runway
RENT
$119M
$13K ﹤0.01%
+77
New +$20.5K
RYAM icon
4199
Rayonier Advanced Materials
RYAM
$570M
$13K ﹤0.01%
2,304
-238
-9% -$1.55K
SBSI icon
4200
Southside Bancshares
SBSI
$986M
$13K ﹤0.01%
322
-1,477
-82% -$61.1K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.